AFM Portaal en AFM-website niet bereikbaar komend weekend
Vanaf vrijdag 4 oktober 21.00 uur tot zondag 6 oktober 21.00 uur is het AFM Portaal niet bereikbaar. Vanaf zaterdag 5 oktober 06.00 uur tot zondag 6 oktober 21.00 uur is de AFM-website niet bereikbaar.
Koninklijke Philips N.V.
Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.
Publicatie datum
04 mei 2011 - 09:30
Statutaire naam
Koninklijke Philips N.V.
Titel
Philips and the Heart Rhythm Society collaborate to showcase the electrophysiology (EP) lab of today and the future
Bericht
San Francisco, USA – At Heart Rhythm 2011, the Heart Rhythm Society’s 32nd annual scientific sessions, May 4-7 in San Francisco, Royal Philips Electronics (NYSE: PHG, AEX: PHI) and the Heart Rhythm Society (HRS) have teamed up to showcase current solutions and future developments that shape the diagnosis and minimally invasive treatment of heart rhythm disorders.
Heart rhythm disorders are caused by disturbed electrical signals that regulate the heart and can lead to serious health risks, including heart failure or stroke. Many rhythm disorders can be treated using minimally invasive electrophysiology (EP) procedures, carried out in an EP lab. These procedures require image guidance and interventional tools that enable physicians to achieve the optimum clinical outcome, while minimizing adverse events.
The industry collaboration between Philips and the Heart Rhythm Society, along with other industry partners, is displayed in the Networked EP Lab. The Lab is an educational pavilion where advanced clinical technologies, new processes and integrated data-sharing solutions are demonstrated to help EP teams optimize patient safety, outcomes and improve procedural management.
“The Networked EP Lab will provide attendees with an opportunity to see what state-of-the-art technology looks like, learn best practices, share ideas and walk away with information to streamline their efforts,” said the Heart Rhythm Society’s Scientific Sessions Abstract Chair, Hugh Calkins, MD, FHRS. “Having all the components in the Networked EP Lab communicate with each other in combination with the most advanced technology will significantly impact education, teaching and patient care, ultimately improving both patient safety and outcomes of treatment.”
Datum laatste update: 06 oktober 2024